Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Sunitinib/zoledronic acid

Osteonecrosis (first report with sunitinib): case report

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Sunitinib/zoledronic acid. React. Wkly. 1241, 37 (2009). https://doi.org/10.2165/00128415-200912410-00107

    Download citation

    Keywords

    • Renal Cell Carcinoma
    • Sunitinib
    • Zoledronic Acid
    • Osteonecrosis
    • Metastatic Renal Cell Carcinoma